# Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)

> **NCT00965809** · PHASE4 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 70 (estimated)

## Conditions studied

- Posttraumatic Stress Disorders

## Interventions

- **DRUG:** Tetrahydrocannabinol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00965809
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2012-10
- **Final completion:** 2013-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965809, "Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00965809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*